Shoker Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.62M | Sell |
21,218
-754
| -3% | -$167K | 1.37% | 18 |
|
|
2025
Q4 | $5.02M | Sell |
21,972
-667
| -3% | -$152K | 1.47% | 16 |
|
|
2025
Q3 | $5.24M | Sell |
22,639
-90
| -0.4% | -$18.3K | 1.55% | 15 |
|
|
2025
Q2 | $4.22M | Sell |
22,729
-475
| -2% | -$88.3K | 1.32% | 17 |
|
|
2025
Q1 | $4.86M | Buy |
23,204
+118
| +0.5% | +$22.9K | 1.64% | 12 |
|
|
2024
Q4 | $4.1M | Sell |
23,086
-306
| -1% | -$56.3K | 1.39% | 17 |
|
|
2024
Q3 | $4.62M | Sell |
23,392
-647
| -3% | -$121K | 1.55% | 14 |
|
|
2024
Q2 | $4.12M | Sell |
24,039
-879
| -4% | -$146K | 1.46% | 15 |
|
|
2024
Q1 | $4.5M | Buy |
24,918
+142
| +0.6% | +$24.5K | 1.61% | 14 |
|
|
2023
Q4 | $3.84M | Buy |
24,776
+110
| +0.4% | +$16K | 1.48% | 15 |
|
|
2023
Q3 | $3.68M | Sell |
24,666
-104
| -0.4% | -$15.3K | 1.6% | 15 |
|
|
2023
Q2 | $3.34M | Sell |
24,770
-7
| -0% | -$1.03K | 1.39% | 17 |
|
|
2023
Q1 | $3.95M | Sell |
24,777
-21
| -0.1% | -$3.21K | 1.72% | 13 |
|
|
2022
Q4 | $4.01M | Sell |
24,798
-870
| -3% | -$133K | 1.8% | 11 |
|
|
2022
Q3 | $3.44M | Buy |
25,668
+504
| +2% | +$72.3K | 1.81% | 16 |
|
|
2022
Q2 | $3.85M | Sell |
25,164
-133
| -0.5% | -$20.3K | 2.05% | 8 |
|
|
2022
Q1 | $4.1M | Sell |
25,297
-96
| -0.4% | -$13.9K | 2.03% | 9 |
|
|
2021
Q4 | $3.44M | Sell |
25,393
-610
| -2% | -$72.1K | 1.58% | 16 |
|
|
2021
Q3 | $2.8M | Buy |
26,003
+400
| +2% | +$45.7K | 1.4% | 19 |
|
|
2021
Q2 | $2.88M | Buy |
25,603
+354
| +1% | +$39.9K | 1.44% | 18 |
|
|
2021
Q1 | $2.73M | Sell |
25,249
-2,757
| -10% | -$295K | 1.43% | 19 |
|
|
2020
Q4 | $3M | Buy |
28,006
+194
| +0.7% | +$18.6K | 1.68% | 13 |
|
|
2020
Q3 | $2.44M | Buy |
27,812
+94
| +0.3% | +$8.85K | 1.6% | 18 |
|
|
2020
Q2 | $2.72M | Buy |
27,718
+255
| +0.9% | +$22.5K | 1.9% | 13 |
|
|
2020
Q1 | $2.09M | Buy |
27,463
+1,113
| +4% | +$94.8K | 1.76% | 16 |
|
|
2019
Q4 | $2.33M | Buy |
26,350
+239
| +0.9% | +$19.8K | 1.55% | 17 |
|
|
2019
Q3 | $1.98M | Buy |
26,111
+1,574
| +6% | +$108K | 1.42% | 22 |
|
|
2019
Q2 | $1.78M | Buy |
24,537
+1,220
| +5% | +$95.9K | 1.3% | 27 |
|
|
2019
Q1 | $1.88M | Buy |
23,317
+219
| +0.9% | +$17.9K | 1.39% | 19 |
|
|
2018
Q4 | $2.13M | Buy |
23,098
+204
| +0.9% | +$17.9K | 1.79% | 16 |
|
|
2018
Q3 | $2.17M | Buy |
22,894
+15
| +0.1% | +$1.42K | 1.57% | 17 |
|
|
2018
Q2 | $2.12M | Sell |
22,879
-397
| -2% | -$38.8K | 1.58% | 17 |
|
|
2018
Q1 | $2.2M | Sell |
23,276
-1,121
| -5% | -$123K | 1.67% | 15 |
|
|
2017
Q4 | $2.36M | Sell |
24,397
-1,041
| -4% | -$98.1K | 1.7% | 13 |
|
|
2017
Q3 | $2.26M | Sell |
25,438
-311
| -1% | -$23.7K | 1.71% | 14 |
|
|
2017
Q2 | $1.87M | Buy |
25,749
+1,455
| +6% | +$97.8K | 1.47% | 19 |
|
|
2017
Q1 | $1.58M | Sell |
24,294
-1,690
| -7% | -$106K | 1.33% | 24 |
|
|
2016
Q4 | $1.63M | Buy |
25,984
+709
| +3% | +$43.3K | 1.35% | 22 |
|
|
2016
Q3 | $1.59M | Sell |
25,275
-223
| -0.9% | -$14.4K | 1.35% | 21 |
|
|
2016
Q2 | $1.58M | Sell |
25,498
-21
| -0.1% | -$1.28K | 1.4% | 20 |
|
|
2016
Q1 | $1.46M | Sell |
25,519
-274
| -1% | -$15.3K | 1.37% | 22 |
|
|
2015
Q4 | $1.53M | Buy |
25,793
+651
| +3% | +$37.5K | 1.53% | 22 |
|
|
2015
Q3 | $1.37M | Sell |
25,142
-678
| -3% | -$44.1K | 1.44% | 19 |
|
|
2015
Q2 | $1.73M | Sell |
25,820
-721
| -3% | -$47.1K | 1.63% | 18 |
|
|
2015
Q1 | $1.55M | Buy |
26,541
+171
| +0.6% | +$10.3K | 1.48% | 19 |
|
|
2014
Q4 | $1.73M | Buy |
26,370
+359
| +1% | +$22.6K | 1.6% | 18 |
|
|
2014
Q3 | $1.5M | Buy |
26,011
+150
| +0.6% | +$8.33K | 1.39% | 22 |
|
|
2014
Q2 | $1.46M | Buy |
25,861
+462
| +2% | +$24.2K | 1.29% | 26 |
|
|
2014
Q1 | $1.31M | Buy |
25,399
+208
| +0.8% | +$10.5K | 1.23% | 27 |
|
|
2013
Q4 | $1.33M | Buy |
+25,191
| New | +$1.24M | 1.22% | 26 |
|
Other funds holding ABBV
VCM
VPM
Shoker Investment Counsel's ABBV Position: Q1 2026 in Review
Shoker Investment Counsel reduced its AbbVie (ABBV) stake by 3.4% in Q1 2026, selling an estimated $167K and leaving 21,218 shares worth $4.62M. The position accounts for 1.37% of the portfolio, ranked #18.
Shoker Investment Counsel first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.24M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Shoker Investment Counsel held 21,218 shares of AbbVie worth $4.62M as of Q1 2026.
- Shoker Investment Counsel sold 754 AbbVie shares in Q1 2026, an estimated $167K.
- AbbVie made up 1.37% of Shoker Investment Counsel's portfolio in Q1 2026, its #18 holding.
- Shoker Investment Counsel first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
- Shoker Investment Counsel's AbbVie position peaked at $5.24M in Q3 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.